UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054741
Receipt number R000062467
Scientific Title Development of the upper limb motor training that facilitates compensatory neural pathways after brain and spinal cord lesions: a pilot study
Date of disclosure of the study information 2024/06/25
Last modified on 2024/12/24 09:45:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of motor training after brain and spinal cord lesions

Acronym

Motor training after brain and spinal cord lesions

Scientific Title

Development of the upper limb motor training that facilitates compensatory neural pathways after brain and spinal cord lesions: a pilot study

Scientific Title:Acronym

Motor training after brain and spinal cord lesions

Region

Japan


Condition

Condition

Cerebral Infarction
Traumatic Spinal Cord Injury
Spinal Cord Infarction
Cervical Spondylotic Myelopathy

Classification by specialty

Neurology Orthopedics Neurosurgery
Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate neurophysiological changes after the short-term upper limb motor training in individuals with and without chronic brain or spinal cord lesion

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Amplitudes of motor-evoked potentials at the end of intervention

Key secondary outcomes

Amplitudes of somatosensory-evoked potentials at the end of intervention
Electroencephalogram-electromyogram coherence at the end of intervention
Electromyogram-electromyogram coherence at the end of intervention
Action Research Arm Test score at the end of intervention
The Graded Redefined Assessment of Strength, Sensibility and Prehension score at the end of intervention
Upper extremity motor score of the international standards for neurological classification of spinal cord injury at the end of intervention
Maximum grip strength at the end of intervention
Maximum pinch strength at the end of intervention
Kinematics of the upper limb during prehension movements at the end of intervention
Fingertip forces during prehension movements at the end of intervention


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Upper limb reaching exercise for 5 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Criteria for healthy participants:
[1] Person who is between 18 and 85 years old
[2] Person without history of upper motor impairments due to neurological or musculoskeletal diseases
[3] Person who is right-handed

Criteria for patients:
[1] Person who is between 18 and 85 years old
[2] Person who has been diagnosed as cerebral infarction, traumatic cervical spinal cord injury, spinal cord infarction, or cervical spondylotic myelopathy, and shows upper motor neuron sign(s)
[3] Person without progression of symptoms more than 6 months after onset or decompression surgeries
[4] Person who is able to reach out and grasp a 5 cm square object 30 cm away from the body

Key exclusion criteria

[1] Person who has uncontrolled medical conditions (severe heart failure, respiratory failure, diabetes mellitus, hypertension, interstitial pneumonia, kidney failure, autoimmune disease, neoplastic disease, psychiatric disease, infection, or dementia)
[2] Person who needs respiratory management with ventilators
[3] Person who has intracranial metallic or magnetic pieces, or pacemakers
[4] Person who has implantable medical devices, person with history of seizures or epilepsy, person who takes medications, which could lower threshold for seizures (e.g. TCAs, neuroleptic agents), person who is suffering from drug abuse or withdrawal symptoms, person who is pregnant
[5] Person who is considered inappropriate to become a participant by a physician
[6] Person who has participated in other clinical studies within 12 weeks and has taken medication in the studies
[7] Person who is participating in other clinical studies
[8] Person who is a minor
[9] Person without sufficient comprehension and judgement due to disease or disability even if the person is a major

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Shinya
Middle name
Last name Suzuki

Organization

Kyorin University

Division name

School of Medicine

Zip code

181-8611

Address

6-20-2 Shinkawa, Mitaka, Tokyo

TEL

0422-47-5511

Email

shinya-suzuki@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Suzuki

Organization

Kyorin University

Division name

School of Medicine

Zip code

181-8611

Address

6-20-2 Shinkawa, Mitaka, Tokyo

TEL

0422-47-5511

Homepage URL


Email

shinya-suzuki@ks.kyorin-u.ac.jp


Sponsor or person

Institute

Kyorin University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine Research Ethics Committee, Kyorin University

Address

6-20-2 Shinkawa, Mitaka, Tokyo

Tel

0422-47-5511

Email

rec@ks.kyorin-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 06 Month 04 Day

Date of IRB

2024 Year 06 Month 13 Day

Anticipated trial start date

2024 Year 06 Month 13 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 06 Month 24 Day

Last modified on

2024 Year 12 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062467